Recent Finacing
Recent Raise
Corvidia Therapeutics, a clinical-stage biotech in Waltham, uses functional genomics to develop precision cardiovascular and cardio-renal therapies, notably monoclonal antibody COR-001 and genetically guided CKD and preclinical programs.
